The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMERISOURCEBERGEN CORP COM 03073E105 10,370 109,700 SH   SOLE   109,700 0 0
ANIKA THERAPEUTICS INC COM 035255108 6,168 125,000 SH   SOLE   125,000 0 0
ANTHEM INC COM 036752103 10,385 55,200 SH   SOLE   55,200 0 0
BIOGEN INC COM 09062X103 6,784 25,000 SH   SOLE   25,000 0 0
CHARLES RIV LABS INTL INC COM 159864107 7,102 70,212 SH   SOLE   70,212 0 0
GILEAD SCIENCES INC COM 375558103 6,908 97,600 SH   SOLE   97,600 0 0
IMMUCELL CORP COM PAR $0.10 452525306 1,335 182,133 SH   SOLE   182,133 0 0
LABORATORY CORP AMER HLDGS COM NEW 50540R409 7,060 45,800 SH   SOLE   45,800 0 0
LIGAND PHARMACEUTICALS INC COM NEW 53220K504 6,823 56,200 SH   SOLE   56,200 0 0
MCKESSON CORP COM 58155Q103 10,382 63,100 SH   SOLE   63,100 0 0
PFIZER INC COM 717081103 6,879 204,800 SH   SOLE   204,800 0 0